AstraZeneca

UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a

AstraZeneca, Honeywell partner to address climate change with new inhaler tech

https://pharmaphorum.com/news/astrazeneca-honeywell-partner-to-address-climate-change-with-new-inhaler-tech/

AstraZeneca/ News/ News/ R&D

Breakthrough designation AstraZeneca’s severe asthma drug

Piotr Wnuk Amgen, AstraZeneca, severe asthma, tezepelumab 0 Comment

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after

Breakthrough designation AstraZeneca’s severe asthma drug

https://pharmaphorum.com/news/astrazeneca-asthma-breakthrough/

AstraZeneca/ Diabetes/ Diabetes/ News/ News/ R&D/ UK & Europe

AstraZeneca improves diabetes pen to maintain its market share

Piotr Wnuk AstraZeneca, Bydureon, Diabetes, GLP-1 0 Comment

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

AstraZeneca/ News/ UK & Europe

AstraZeneca changes contractors as HQ delayed again

Piotr Wnuk AstraZeneca, Cambridge (UK) 0 Comment

AstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters,

AstraZeneca changes contractors as HQ delayed again

https://pharmaphorum.com/news/astrazeneca-changes-contractors-as-hq-delayed-again/

AstraZeneca/ News/ News/ R&D

AstraZeneca to present the latest cardiovascular research

Piotr Wnuk AstraZeneca, cardiovascular, hyperkalaemia, MedImmune 0 Comment

AstraZeneca and MedImmune will present new data from its Cardiovascular, Renal and Metabolism (CVRM) portfolio for the treatment

AstraZeneca to present the latest cardiovascular research

https://pharmaphorum.com/news/astrazeneca-presents-latest-cardio-research/

Iraq Flag 3D Rendering on Blue Sky Building Background

AstraZeneca/ News/ Pfizer/ Roche

Drug firms fight US government’s Iraq corruption probe

Joy Persaud litigation 0 Comment

US Department of Justice investigating J&J, Pfizer, Roche and others

Drug firms fight US government’s Iraq corruption probe

https://pharmaphorum.com/news/drug-firms-fight-us-governments-iraq-corruption-probe/

AstraZeneca/ Merck Inc/ News/ News/ News/ Oncology/ R&D/ Rare diseases/ Top stories/ UK & Europe

Neurofibromatosis treatment granted orphan status by EMA

Piotr Wnuk ASCO 2018, AstraZeneca, ema, genetic, Merck & Co, Neurofibromatosis, NF1, Oncology, Selumetinib 0 Comment

AstraZeneca and Merck & Co. announced the European Medicines Agency (EMA) has granted orphan designation to their codeveloped

Neurofibromatosis treatment granted orphan status by EMA

https://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/

AstraZeneca/ Market Access/ News/ News/ Top stories

AZ suffers setback as NICE slaps restrictions on Fasenra

Richard Staines AstraZeneca, market access, respiratory 0 Comment

Fasenra can only be used after GSK rival, NICE says in draft decision

AZ suffers setback as NICE slaps restrictions on Fasenra

https://pharmaphorum.com/news/az-suffers-setback-as-nice-slaps-restrictions-on-fasenra/

AstraZeneca/ News/ News/ R&D/ Top pharmaceutical companies

AZ forges surprise R&D deal with virus gene therapy biotech

Piotr Wnuk AstraZeneca, gene therapy, genetics, MedImmune 0 Comment

MedImmune, the R&D arm of AstraZeneca has teamed up with California based 4DMT, a next-generation virus-based gene therapy

AZ forges surprise R&D deal with virus gene therapy biotech

https://pharmaphorum.com/top-pharmaceutical-companies/astrazeneca/az-steps-avv-field-medimmune-4dmt/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

AstraZeneca

Login